← Back to headlines
Allogene Therapeutics Names Zachary Roberts as New CEO
Allogene Therapeutics has appointed Zachary Roberts as its new Chief Executive Officer, part of a planned succession.
28 May, 21:29 — 28 May, 21:29
Sources
Showing 1 of 1 sources


